Live feed16:06:18·1123dSECFilingvia QuantisnowNGM Biopharmaceuticals Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.NGM· NGM Biopharmaceuticals Inc.Health CareOriginal source
